Retail Pharmacies Take Big Hit After Amazon's PillPack Deal

The day the retail giant announced plans to acquire the online pharmacy company PillPack, competing retail pharmacy companies took a significant blow. Eight companies, including CVS and Rite Aid, dropped $17.5 billion in market cap in just one day. For full interview, [click here](https://cheddar.com/videos/amazon-acquisition-of-pillpack-crushes-shares-of-walgreens-cvs-rite-aid).

More In Business

Inside The Hidden Risks of Trump’s Housing Plan

Peachtree Group CEO Greg Friedman unpacks what a ban on institutional homebuyers could mean for affordability.

Discover The Minerals Powering America’s Tech Boom

Rita Adiani, CEO of Titan Mining, explains why graphite, zinc, and germanium are becoming vital to U.S. industry and security.

Inside Aeva's New Deal with Nvidia

Aeva CEO Soroush Salehian breaks down what the NVIDIA partnership signals for autonomous vehicles and the future of automation.

Inside Goodwill’s Retail Reinvention: Why People Can't Stop Thrifting

David Eagles, COO of Goodwill Industries International, explains how resale, culture shifts, and economics are fueling a secondhand boom.

Your 2026 Money Reset Starts Now

Personal finance reporter Oyin Adedoyin of The Wall Street Journal breaks down the smartest moves to reset savings, debt, and spending.

A Housing Fix or a Political Play? Trump Targets Institutional Buyers

Jeff Ostrowski, Housing Market Analyst at Bankrate, analyzes whether banning corporate buyers would help affordability or worsen supply shortages.

Big Business This Week: Will pressure on Fed chair Powell backfire?

The last 12 months have seen an extraordinary change in the way the U.S. economy works. Some analysts say that hasn’t been working out very well.

Oil Under U.S. Control? Breaking Down the Maduro Capture and Market Impacts

The U.S. is asserting control over Venezuelan oil after capturing President Maduro. Energy reporter Ben Geman of Axios breaks down what it means for markets and

From Stigma to Strategy: The Next Chapter for U.S. Cannabis Investing

Renewed investor interest and possible federal reforms may mark a turning point for U.S. cannabis. AdvisorShares’ Dan Ahrens explains what’s next.

Is Silver the Next Gold? Expert Predicts Historic Rally Ahead

Silver is back in the spotlight as supply constraints, surging industrial demand, and macro trends push prices high, possibly heading toward $100/ounce.

Load More